OKYO Pharma (OKYO) Assets Average (2022 - 2025)

OKYO Pharma (OKYO) has 4 years of Assets Average data on file, last reported at $4.2 million in Q3 2025.

• Assets Average for Q3 2025 came in at $4.2 million, up 90.41% year-over-year; the trailing twelve-month figure through Sep 2025 was $4.2 million (up 90.41% YoY), and the FY2025 annual result was $2.6 million, down 22.63% from the prior year.
• Assets Average rose to $4.2 million in Q3 2025 per OKYO's latest filing, from $3.3 million in the prior quarter.
• Over five years, Assets Average peaked at $5.7 million in Q1 2022 and troughed at $2.0 million in Q1 2024.
• A 4-year average of $3.7 million and a median of $3.8 million in 2023 frame the typical range for Assets Average.
• The sharpest annual moves came in 2024 and 2025: Assets Average tumbled 58.77% in 2024, then soared 90.41% in 2025.
• A 4-year view of Assets Average shows it stood at $5.7 million in 2022, then slumped by 33.45% to $3.8 million in 2023, then plunged by 42.36% to $2.2 million in 2024, then soared by 90.41% to $4.2 million in 2025.
• Business Quant data shows OKYO's Assets Average at $4.2 million in Q3 2025, $3.3 million in Q1 2025, and $2.2 million in Q3 2024.